Coya Therapeutics (COYA) Interest Expenses (2021 - 2026)

Coya Therapeutics (COYA) has 6 years of Interest Expenses data on file, last reported at $604495.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 85.52% year-over-year to $604495.0; the trailing twelve-month figure through Mar 2026 stood at $604495.0 (down 85.52% YoY), and the FY2025 full-year result was $13.3 million, up 63.77% from the prior year.
• Interest Expenses retreated to $604495.0 in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $9.8 million in Q1 2024 to a low of $604495.0 in Q1 2026.
• A 5-year average of $3.4 million and a median of $2.6 million in 2025 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses soared 802.47% in 2024 and sank 85.52% in 2026, its largest moves.
• Tracing COYA's Interest Expenses over 5 years: stood at $1.0 million in 2022, then soared by 462.51% to $5.6 million in 2023, then surged by 44.51% to $8.1 million in 2024, then plunged by 68.79% to $2.5 million in 2025, then plunged by 76.17% to $604495.0 in 2026.
• Business Quant data shows COYA's Interest Expenses at $604495.0 in Q1 2026, $2.5 million in Q4 2025, and $2.4 million in Q3 2025.